Details for Patent: 4,053,628

Summary for Patent: 4,053,628

Patent landscape, scope, and claims:

Title:	Composition
Abstract:	There is described a composition comprising a substantially clear, sterile aqueous solution containing as active ingredient a therapeutically useful proportion of 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol, or a pharmaceutically acceptable (e.g. the di-sodium) salt thereof, or of 5,5'-[[5,5'-(2-hydroxytrimethylene)dioxy]bis[4-oxo-4H-1-benzopyran-2-yl]]t etrazole, or a pharmaceutically acceptable (e.g. the di-sodium) salt thereof. The composition is indicated for the treatment of conditions of the eye and the nose.
Inventor(s):	Stevenson; Neil Arthur (Loughborough, EN), Wardell; George (Loughborough, EN)
Assignee:	Fisons Limited (London, EN)
Application Number:	05/677,274
Patent Claim Types: see list of patent claims	Use; Composition; Formulation;

Drugs Protected by US Patent 4,053,628

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,053,628

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	14529/71	May 12, 1971
	57169/71	Dec 9, 1971
	25237/73	May 25, 1973
	25238/73	May 25, 1973

International Family Members for US Patent 4,053,628

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	4208072
Australia	465305
Belgium	782981
Canada	1000201